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The Down syndrome cell adhesion molecule 1 (Dscam1) gene is an extraordinary 
example of diversity: by combining alternatively spliced exons, thousands of isoforms 
can be produced from just one gene. So far, such diversity in this gene has only been 
found in insects and crustaceans, and its essential part in neural wiring has been well- 
characterized for Drosophila melanogaster. Ten years ago evidence from D. melanogas-
ter showed that the Dscam1 gene is involved in insect immune defense and work on 
Anopheles gambiae indicated that it is a hypervariable immune receptor. These exciting 
findings showed that via processes of somatic diversification insects have the possi-
bility to produce unexpected immune molecule diversity, and it was hypothesized that 
Dscam1 could provide the mechanistic underpinnings of specific immune responses. 
Since these first publications the quest to understand the function of this gene has 
uncovered fascinating insights from insects and crustaceans. However, we are still far 
from a complete understanding of how Dscam1 functions in relation to parasites and 
pathogens and its full relevance for the immune system. In this Hypothesis and Theory 
article, we first briefly introduce Dscam1 and what we know so far about how it might 
function in immunity. By focusing on seven questions, we then share our sometimes 
contrasting thoughts on what the evidence tells us so far, what essential experiments 
remain to be done, and the future prospects, with the aim to provide a multiangled view 
on what this fascinating gene has to do with immune defense.
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introdUCtion
Dscam1: Mutually exclusive alternative splicing Generates 
isoform diversity
There are few genes that encode for such extreme molecular diversity as Dscam1, the insect and crus-
tacean homolog of the human Down syndrome cell adhesion molecule (DSCAM) (1, 2). Although 
Dscam1 shares homology with DSCAM, only Dscam1 has evolved the possibility to produce a 
profusion of protein isoforms. Since Dscam1 was discovered as a cell surface hypervariable axon 
FiGUre 1 |  Dscam1 in Drosophila melanogaster and known occurrence of Dscam1 in arthropods. (a) D. melanogaster Dscam1 genomic DNA structure contains 
20 constant exons (black lines). Four exon clusters contain variable numbers of alternative exons (colored lines): exon 4 contains 12, exon 6 contains 48, exon 9 
contains 33, and exon 17 contains 2 variants. (B) Dscam1 mRNA contains every constant exon (white boxes), but through the process of mutually exclusive 
alternative splicing, only one of each of the alternative exons is present in each mRNA; one exon combination for D. melanogaster is illustrated. (C) Dscam1 protein 
structure, where Ig indicates an immunoglobulin domain and FNIII indicates a fibronectin type III domain. The alternatively spliced exons encode the N-terminal 
halves of Ig2 and Ig3, all of Ig7, and the transmembrane domain. (d) Ig1 to Ig4 form a horseshoe configuration (24). Epitope I is one side of the horseshoe and in the 
nervous system engages in homophilic binding with identical Dscam1 isoforms coded for by the identical exon 4, 6, and 9 variants; the other side of the horseshoe, 
epitope II, has been proposed to bind to non-Dscam1 ligands, i.e., pathogen-related ligands. [(a–d) after (16)]. (e) Dscam1 as illustrated in (a–C) has, to date, only 
been found in pancrustaceans. Myriapods and chelicerates have diversified the Dscam gene family via other routes. *Crustacea is considered a paraphyletic group 
containing the hexapods; phylogeny follows Legg et al. (17).
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guidance receptor in D. melanogaster (2), our knowledge of its 
functions in the nervous system and the immune system as well 
as its evolution across insects and crustaceans (i.e., the subgroup 
of the arthropods that is called Pancrustacea) has expanded 
extensively [reviewed in Ref. (3–10)], yet we are still far from a 
complete understanding of how Dscam1 reacts and responds to 
parasites and pathogens.
Dscam1 [synonymous with Dscam, Dscam-hypervariable 
(Dscam-hv) and species-specific notations, e.g., the shrimp 
Litopenaeus vannamei Dscam1 has been named LvDscam] has 
a complex gene structure whereby clusters of alternative exons 
encode for different immunoglobulins (Igs) domains (Figure 1). 
As an example, in D. melanogaster exons 4, 6, and 9 have numer-
ous alternative sequences (2). Exon 4 has evolved 12 alternative 
variants, exon 6 has 48 [of which 47 are transcribed (11–13)], 
and exon 9 has 33 variants (Figure 1A). The number of alterna-
tive variants is not conserved across species, but the existence of 
multiple variants within three exon clusters is consistent across 
all pancrustaceans studied to date. However, in species other than 
D. melanogaster, the orthologous exon clusters sometimes have 
different numbering [e.g., exons 4, 6, and 10 in Anopheles gam-
biae (14)] because of differing positions of exon–exon bounda-
ries. The pre-mRNA undergoes mutually exclusive alternative 
splicing, so that each mRNA contains only one of the pos-
sible variants from each of the three alternative exon clusters 
(Figure 1B). Across species, the alternatively spliced exons code 
for the N-terminal halves of Ig2 and Ig3 and the whole of Ig7 
(Figure  1C). These Ig domains are located in the extracellular 
portion of the protein. Mutually exclusive alternative splicing of 
the exons encoding the extracellular region, could potentially 
lead to the production of 12 × 48 × 33 = 19,008 gene isoforms 
(18,612 if the non-transcribed exon in cluster 6 is excluded). If 
exon 17, which has two alternatively spliced variants and encodes 
the transmembrane region of the protein, and exons 19 and 23, 
which can be contained within or skipped from the cytoplasmic 
region of the protein (15), are included in the isoform diversity 
calculation, the estimate increases to just under 150,000 gene 
isoforms. This is an incredible amount of diversity to be expressed 
by just one gene.
involvement in the nervous system
Our knowledge about Dscam1’s function in the nervous system 
comes predominantly from research on D. melanogaster, where it 
has been extensively reviewed [e.g., Ref. (3–5, 9, 16, 18, 19)]. The 
diverse extracellular domains of the Dscam1 protein facilitate its 
function as a molecular surface code, which enables neurites to 
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tell self from non-self, thus avoiding neuronal self-connectivity 
(5). Homophilic binding, i.e., binding between identical isoforms 
and subsequent repulsion, is the key to Dscam1’s function in 
self-recognition. In brief, expression analyses have estimated 
that individual cells produce a much reduced portion of the total 
number of possible isoforms, i.e., in the order of tens of isoforms, 
and that cells produce a suite of isoforms that are different to their 
neighboring cells (11). These two points are important because 
they make it highly likely that sister neurites from the same 
neuron will express identical Dscam1 isoforms that will in turn 
differ from the neighboring cells; identical isoforms will bind to 
each other, but not at all, or only weakly, to non-identical isoforms 
(20, 21). Once identical isoforms have interacted, the protein’s 
endodomain (cytoplasmic tail) converts isoform recognition into 
repulsion between the sister neurites and promotes self-avoidance 
(22). In the nervous system the identity of each isoform, i.e., the 
combination of exons 4, 6, and 9 that encode it, does not mat-
ter, but it is essential that neighboring neurons express different 
isoforms from one another (23). Non-self recognition is thereby 
effectively a game of probabilities, where the number of potential 
Dscam1 isoforms and the number of and stochasticity with which 
cells express Dscam1 isoforms determine the rules. In contrast 
to the nervous system, if Dscam1 diversity affords the immune 
system the ability to discriminate between different pathogens, 
it is hypothesized that the identity of individual isoforms does 
matter.
one protein, two roles?
Elucidation of the protein structure of D. melanogaster Dscam1 
hinted at how one protein might function in both the nervous 
system and the immune system. D. melanogaster Dscam1 Ig1 to 
Ig4 form a horseshoe configuration, with an independent interac-
tion surface on either side of the horseshoe (24). Some of the 
amino acids encoded for by exons 4 and 6 can be found on either 
one (epitope I) or the other (epitope II; Figure 1D) interaction 
surfaces. By swapping peptide segments, Meijers et al. (24) found 
that it is epitope I that engages in homophilic binding specificity, 
whereas epitope II was hypothesized to bind to non-Dscam1 
ligands, i.e., heterophilic binding. It has not to date been demon-
strated empirically that epitope II binds to non-Dscam1 ligands, 
but it has been hypothesized that the ligands could be antigens, 
thereby affording Dscam1 an immune receptor function. It was 
then discovered that upon homophilic binding, Ig5–Ig8 also form 
a turn in the protein but in the opposite direction to Ig1–I Ig4, 
which means that Ig1–Ig8 together make up a serpentine or “S” 
shape, binding homophilically in an antiparallel manner (25). 
Similar to Ig2 and Ig3, it is not known whether Ig7 is involved in 
heterophilic binding.
Dscam diversity in arthropods
Taking a broader phylogenetic perspective, diversity is a common 
theme in the Dscam gene family. Although to date only pancrus-
taceans have been found to share Dscam1 and its extreme somatic 
diversification, species from two other arthropod taxa, chelicer-
ates (e.g., ticks), and myriapods (e.g., centipedes) have evolved 
diversity via whole gene duplication and some degree of alterna-
tive splicing (Figure 1E). For example, Dscam gene duplication 
in the centipede Strigamia maritima genome is estimated to have 
led to 60–80 Dscam genes and in the tick Ixodes scapularis to 
between 13 and 27 (26, 27). To date, there is no evidence of arrays 
of duplicated exons in chelicerate or myriapod Dscam Ig2 or Ig3; 
however, mutually exclusive alternative splicing does occur in the 
exons encoding for Ig7 in at least one S. maritima Dscam gene, 
and duplicated exons coding for Ig7 and Ig8 were found in four 
I. scapularis genes (26). Furthermore, two Dscam gene subfami-
lies have also recently been uncovered in the Chinese scorpion 
Mesobuthus martensii; the genes are shorter than Dscam1 but 
contain Ig domains that correspond to Ig7 or Ig7 and Ig8, as well 
as multiple tandem exon arrays (28).
Dscam1 and immune defense  
in pancrustaceans
Pancrustaceans do not have the same mechanisms for acquired 
(adaptive) immune defenses as vertebrates, i.e., somatic gen-
eration of receptor diversity by V(D)J joining of antibody genes 
followed by clonal selection of antigen-specific lymphocytes 
(29), which underlie immunological memory. They instead 
rely on the evolution of diverse innate immune defenses, which 
share a number of conserved features with the innate defenses 
of vertebrates (27, 30). Nonetheless, some pancrustaceans and 
other non-vertebrates show evidence of a phenomenon similar to 
immune memory, termed “immune priming” (31), and they can 
also somatically generate a limited amount of receptor diversity 
by alternative splicing [e.g., Ref. (32)], albeit that this diversity is 
many orders of magnitude lower than in vertebrates.
The link between Dscam1 and pancrustacean immunity has 
been extensively reviewed in the last few years and we refer 
readers to the following reviews for more details (6–8, 10). Here 
we briefly describe evidence linking Dscam1 to the immune-
function hypotheses that have been proposed. Early studies 
on Dscam1 in D. melanogaster (12) hypothesized that it may 
function as a signaling receptor or coreceptor during phagocy-
tosis and potentially as an opsonin [i.e., bind to the surface of 
a pathogen, facilitating its phagocytosis (29)]. Following this, 
work on A. gambiae also suggested the hypothesis that Dscam1 
could act as a hypervariable pattern-recognition receptor for 
the immune system (14). Consistent with Dscam1 playing a 
role as an opsonin, a shorter soluble Dscam1 protein was found 
in S2 cell line-conditioned medium and also in haemolymph 
serum (12). Furthermore, Dscam1 in the shrimps L. vannamei 
and Penaeus monodon and the Chinese mitten crab Eriocheir 
sinensis lacks the transmembrane domain and cytoplasmic tail 
and has been suggested to be secreted directly into the haemo-
lymph (33–35). It was also shown that recombinantly expressed 
Dscam1 protein binds to pathogens [(12), (36 this article has 
since been retracted), (37)].
Reducing Dscam1 via RNA interference (RNAi), or mutation, 
or antibody blocking of Dscam1 function, lead to the reduced 
phagocytosis of dead bacteria (12, 14), and to the hypothesis 
that Dscam1 acts as a phagocytosis receptor. The membrane-
bound protein has been hypothesized to interact directly with 
the bacteria or it could interact with an opsonizing Dscam1 that 
has already bound to a pathogen (6, 38). Dong et  al. (14) also 
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showed that after A. gambiae infection with bacteria, a fungus, 
or protozoan parasites, Dscam1 exon 4 produces distinct mRNA 
splice variants in response to each antigen (exons 6 and 10 were 
not tested). Dscam1 has generated intense interest in the field 
of pancrustacean (ecological) immunology largely because it was 
hypothesized that the somatic diversity generated by this gene 
has a function in the recognition of diverse parasite and pathogen 
antigens. However, we are far from understanding whether, and if 
so how, this might be the case.
our aims
In this Hypothesis and Theory article, we bring together the 
ideas of six researchers who have contributed toward our cur-
rent knowledge on Dscam1 in immune defense. Through our 
responses to seven questions, we discuss different perspectives 
and hypotheses on what the evidence tells us so far and our ideas 
for future progress on this controversial topic.
Question 1. Looking Back at 10 years of Research on 
a Potential Immune Function of Dscam1, Do You 
Think That Dscam1 Has a Role in Pancrustacean 
Immunity?
Daniela Brites and Louis Du Pasquier
Yes. The main reason why we think that Dscam1 has an immu-
nological role is the fact that the diversity of its repertoires 
(splice variants) that are expressed in cells of the nervous system 
and in cells involved in immunity (fat body cells and equivalent 
and hemocytes) are different. Dscam1 might, therefore, fulfill 
functions that are specific to each of these systems, rather 
than have a single general purpose, which would have been 
suggested by identical repertoires in both tissues. Differences 
in exon expression patterns between the nervous and immune 
systems have been observed both in Drosophila and in Daphnia 
(12, 39). There is a lower diversity in the immune system than 
in the nervous system. This argues that the two repertoires 
are under different selection pressures and/or constraints. 
This restrictive evaluation may look a little provocative, but 
indeed the role of Dscam1 in immunity is still mysterious. As 
many reviews written recently point out, the situation remains 
unclear, with pros and cons (6, 7, 10, 40). There are too many 
contradictory reports concerning: (1) Dscam1 expression, 
whether monitored at the RNA level by PCR or at the protein 
level in binding assays or Western blots (up, down regulation or 
no change following stimulation); (2) the immunological speci-
ficity of its isoforms and the amplification of selected isoforms 
that has not been reproduced or convincingly demonstrated 
following exposure to parasites or other antigens; (3) its role 
as a phagocytic receptor; (4) the mode of signaling suggested 
by the composition of its cytoplasmic segment. The situation is 
complicated by the fact that Dscam1 in pancrustaceans is not 
encoded in a uniform way (26). There are major differences in 
gene numbers and in types of alternative splicing from cheli-
cerates to pancrustaceans (28). Even within pancrustaceans 
there could be room for differences in the mode of expression 
(e.g., importance of the soluble form) resulting in modulations 
of Dscam1 role in immunity.
Yuemei Dong
Dscam1 in insects was first characterized as a highly diverse axon 
guidance molecule in the neuron system of fruit flies (2, 4, 5). In 
the past decade, the studies of Dscam1 in mosquitoes and other 
pancrustaceans have established it as an essential hyper-variable 
pattern recognition receptor (PRR) of the innate immune system, 
mainly contributed by the extraordinary splice form generation 
at the molecular level (12, 14, 36, 37, 39).
Han-Ching Wang
As a crustacean immunologist, I think there is now consider-
able evidence to suggest that Dscam1 might be involved in 
immunity against non-self molecules in long-lived crustaceans 
such as shrimp. Dscam1 shows a typical fast (2–6 h) non-specific 
immune response to pathogen-associated molecular patterns 
(PAMPs) such as lipopolysaccharide (LPS) and beta-1,3-glucan 
(41, 42), but unlike most innate immune factors, Dscam1 is not 
always induced immediately after immune stimulation. Instead, 
viruses and bacteria usually take more than 24  h to induce 
elevated Dscam1 levels (37, 43, 44). In crayfish, this increased 
expression usually reaches a maximum after 5 days and then falls 
back to baseline levels (44). However, overall expression levels 
are not the only indication of Dscam1’s role in immunity, and it 
now appears that the correct combination of Dscam1 isoforms 
might be more important. For instance, we have found that some 
of the pathogen-induced Dscam1 isoforms induced after chal-
lenge with a particular pathogen show significantly greater bind-
ing ability to that same pathogen (37). We have also found that 
the haemolymph taken from “super-survivor” crayfish within 
1  month of white spot syndrome virus (WSSV) challenge can 
provide protection to other animals against the same virus (44). 
Furthermore, when the Dscam1 in this haemolymph is blocked, 
this protection is lost (44). At the very least, it therefore seems that 
crayfish Dscam1 shows an ability to support an extended, specific 
anti-virus immune response.
Sophie A. O. Armitage and Joachim Kurtz
It is clear that Dscam1 is involved in immune defense in some 
contexts in some insects and crustaceans. However, is difficult 
with the current data to determine exactly what this role is, how 
important it is, and the generality of its importance (7, 10). For 
example, immune gene expression (total or alternatively spliced 
variants) after exposure to a pathogen or parasite shows varied 
results across studies [reviewed in Ref. (7, 10)], and gene knock-
down can reduce survival after infection (14), but it can also have 
no effect on survival (40). Furthermore, some host–pathogen 
interactions seem to provide more convincing evidence [e.g., A. 
gambiae and Plasmodium spp. (14, 45)] than others (40) for a role 
of Dscam1 in immunity. Dscam1 might not necessarily play an 
important role in all taxa, but instead be an “add-on” to immunity, 
where described phenomena are the side effects of e.g., altered 
hemocyte behavior. It is also worth bearing in mind that only a 
tiny fraction of the extremely speciose Pancrustacea have been 
examined to date. We do not know whether Dscam1 publishing 
bias exists, in terms of an under-representation of “negative 
results,” but should unpublished data be sitting on someone’s hard 
drive it could be helpful to share this information to unravel the 
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conditions under which Dscam1 does or does not respond in an 
immunological context.
Question 2. Dscam1 Was Hypothesized to Produce 
the Large Number of Variable Receptors Needed for 
Specificity in the Immune Response, in Some Ways 
Analogous to Antibodies in Vertebrates. Do You 
Think That Dscam1 Is Indeed the Equivalent of 
Antibodies As Specific Immune Receptors?
Daniela Brites and Louis Du Pasquier
No. We think that there is a lot of confusion around the Dscam1 
analogy with antibodies. With respect to Dscam1’s somatically 
acquired diversity we think that the analogy with antibody diver-
sity has been over-emphasized even though a warning had been 
formulated at the very beginning (46). One has had the tendency 
to compare apple and oranges. To be analogous to antibodies, 
Dscam1 isoforms, specific to a pathogen epitope, should be 
secreted by some clones of uncommitted hemocytes that resulted 
from the stimulation of a precursor cell expressing the relevant 
Dscam1 specificity. This is what happens in the adaptive immune 
system of vertebrates where specifically stimulated uncommitted 
B lymphocytes, the DNA of which has been somatically modified 
to encode a single receptor specificity per cell, proliferate (i.e., 
generating a clone) and differentiate into secreting plasma-cells 
that release large amounts of one antibody. Today, so far, noth-
ing of the above applies to Dscam1. Since Dscam1 variability is 
produced at the RNA level, it is not inheritable in the progenies 
of cells, would those cells where splicing occurred divide. But 
anyway there are so far no reported specifically induced prolifera-
tive responses of Dscam1 producing cells. Unlike what has been 
proposed (47) there is no clonal amplification of the cells produc-
ing Dscam1. In addition adult flies do not produce new cells from 
the hematopoietic organs. However, one should be careful not to 
generalize from a single species or stage. In fact in the light of the 
interesting recent observations of transdetermination and prolif-
eration of hemocyte lineages reported in D. melanogaster larvae, 
it might become interesting to follow Dscam1 expression on 
those cells even though no information on their clonality is avail-
able (48). One speaks carefully of “demand adapted increase in 
hemocyte proliferation.” Increases in cell numbers in parasitized 
flies have been reported as being due to proliferative response 
but an increase from 0 to 1,000 cells in 6 h cannot be due to a 
simple proliferation. There is here something new to investigate. 
There have been many examples of induction of Dscam1 gene 
expression after some “antigenic” exposure (Membrane form? 
Soluble form? This is not always specified). In addition, significant 
increases in Dscam1 diversity were observed in parasite-exposed 
mosquitoes (49). Increasing diversity after immunization does 
not make Dscam1 a likely analog of antibodies. Indeed, follow-
ing immunization one would rather see the amplification of one 
or two useful variants with some specificity like in antibody 
responses. Increasing diversity means lowering the concentra-
tion of single isoforms and therefore offering minimal chances 
for profiting from a special binding property. But we may simply 
not understand the mode of action of Dscam1. Since apparently 
a single cell expresses more than one Dscam1 isotype (a profound 
difference compared to uncommitted lymphocytes) the best that 
can be produced is a “shot gun” of unrelated Dscam1 molecules 
(8). This leads us to an issue that has been often neglected: the 
concentration of each isoform either on the cell surface in the 
hemocyte population, or in the biological fluids. If one assumes 
that one variant of Dscam1 has a better avidity for its ligand, how 
can this advantage be exploited? It is difficult to imagine the util-
ity of a single variant diluted in the middle of thousands of other 
forms, so there is a need for selection and amplification steps. 
Those are difficult to conceive in a system where diversification is 
due to mutually exclusive alternative splicing and without specific 
cell proliferation. Therefore, Dscam1 diversity might have a func-
tion other than being a repertoire of antigen reactive molecules.
Yuemei Dong
Lacking in vertebrate antibodies, insects rely on relatively small 
numbers of PRRs to combat various pathogens during their com-
plex life cycles, which for a long time lead researchers to believe 
that the immune system in the invertebrates is not as sophisticated 
as its counterpart in the vertebrates (50–53). The genetic expan-
sion of Dscam1 and its ability to generate enormous pathogen 
specific receptors through immune responsive alternative splic-
ing have equipped insects with a similar level of complexity at 
the molecular level, and thereby generate astounding analogs to 
antibodies. The rapid progress of Dscam1 research in immunity 
has marked its role and importance in insect immunity, a ground-
breaking contribution that blurs the classical strict clarification 
between innate and adaptive immunity (12, 14, 39, 53). Innate 
immunity used to be defined as being dependent on germ line 
encoded receptors, rather than recombination of somatically 
expressed antibodies, therefore Dscam1’s role in immunity fits the 
strict definition of innate immunity as it is germ line encoded, but 
not in the sense of the definition as Dscam1 produces immune 
responsive splice forms. The vast diversity of the antibody system 
is clearly adaptive, hypothetically Dscam1 also seems adaptive 
when considering it can produce tens of thousands potential 
splice variants.
Han-Ching Wang
The three hallmarks of acquired immunity are immune diversity, 
immune specificity, and immune memory (51). Mammalian 
antibody-based immune systems have all of these abilities; 
however, although there is evidence to suggest that Dscam1 is 
also able to support all of these functions, Dscam1 would have to 
provide these functionalities via different mechanisms than those 
used by antibodies. Dscam1 is capable of immune diversity and 
immune specificity through alternative RNA splicing (2, 14, 33, 
35, 39, 44, 45). However, after pathogen challenge, we still do not 
know whether immune cells in pancrustaceans are somehow able 
to actively design the particular alternative exons that show the 
ability to bind to the pathogen, or alternatively, whether popula-
tions of pathogen-induced specific Dscam1 isoforms are created 
either through positive selection or by the same kind of negative 
selection mechanism that is used in vertebrate adaptive immune 
systems. Another curious similarity between Dscam1 and anti-
bodies is that whereas antibody diversity/specificity is achieved 
by combinations of three gene segments, V(D)J, Dscam1 hyper-
variability is achieved via three variable exon regions, Ig2/Ig3/
Ig7. Furthermore, since most Dscam1 studies have so far focused 
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primarily on particular variants rather than the whole Ig2/Ig3/
Ig7 Dscam1 combination, we might therefore be underestimat-
ing the potential immune specificity of Dscam1. Maintenance 
of the appropriate Dscam1 populations is another problem, and 
immune memory in pancrustaceans is still an open question. 
In antibody-based mammalian immune systems, memory is 
achieved by somatic changes, but in pancrustaceans, to date, no 
convincing model of immune memory has yet been established.
Joachim Kurtz
My answer depends on what we mean when we say “equivalent.” 
The original view that Dscam1 might function like antibodies 
[e.g., Ref. (38, 47, 50)] was probably a bit too optimistic, since 
several crucial elements could as of yet not be demonstrated and 
are maybe unlikely to exist: there seems to be no clonal amplifica-
tion of the cells that produce the “right” isoforms, and maybe no 
receptor for Dscam1 that could serve a similar role as the Fc recep-
tor for a hypothetical opsonin-like function of Dscam1. Having 
said this, we should still be aware that being “equivalent” does 
not mean that everything has to be similar, and if we search for 
an equivalent system to produce somatically diversified receptors, 
then Dscam1 is still “alive and kicking.” It is reasonable to assume 
that some form of somatic diversification is needed to produce 
a sufficiently large pathogen receptor repertoire that would be 
needed for specificity in discrimination among a large number of 
potential antigens. As of yet, we have only very limited evidence 
that pancrustaceans are actually able to achieve such a very high 
level of specificity in their pathogen and parasite defenses [e.g., 
Ref. (54)]. But if they are able, Dscam1 is currently the only 
system known for pancrustaceans that could at least theoretically 
provide the needed receptor diversity. However, critical tests of 
the involvement of Dscam1 in the specificity of immune reactions 
are still lacking.
Sophie A. O. Armitage
Through combinatorial diversification of vertebrate variable, 
diversity and joining gene segments (V(D)J) millions of combina-
tions can be produced, and this number is in the order of billions 
of antibody molecules as a result of junctional diversification and 
somatic hypermutation (55). Dscam1, on the other hand, shows 
many orders of magnitude less diversity than vertebrate antibod-
ies. Through ultra-deep sequencing of D. melanogaster Dscam1 
mRNA using next generation sequencing, Sun et al. (13) detected 
18,496 of the possible 19,008 isoform combinations for exons 4, 6, 
and 9. However, D. melanogaster fat body and hemocytes do not 
express the full range of particularly the exon 9 cluster (11, 12), 
which could considerably reduce the total isoform estimation. 
Therefore, in addition to the above responses to this question, 
in terms of variation, Dscam1 does not produce diversity that is 
equivalent to that produced by antibodies as specific immune 
receptors.
Question 3. Next to Specificity, Remembering  
Is a Key Aspect of Immune Memory. Could This  
Be Achieved with Dscam1?
Daniela Brites and Louis Du Pasquier
No, according to our conservative concept of memory! Memory, 
in an immunological sense, demands clonal amplification and 
storage of specialized cells. It implies a reactivation of those 
cells after the initial antibody response has been down regulated 
(anamnestic response). This does not happen in any invertebrate 
and more specifically it does not happen in the Dscam1 case. 
However, if some soluble form with specificity persists, the pro-
tection that it may confer can persist: it will be called memory by 
some but not by classical immunologists who see then a persist-
ing on-going response or the long survival of a protecting agent 
and not the proper “recall” that characterizes memory responses.
Yuemei Dong
Evolution might have taken different routes to achieve functional 
similarities with Dscam1 splice clouds in the invertebrates’ and 
antibodies in the vertebrates’ immunity. Given the two major 
features of adaptive immunity, immune specificity and memory, 
much of the work about Dscam1’s role in adaptive-resembling 
immunity was focused on addressing the pathogen recognition 
diversities and specificities. Quite some studies have shown that 
past infections influence insects’ humoral and cellular immune 
system thereby protecting the host from the second and the 
following pathogenic infections (53, 56–62). So-called immune 
priming or trained immunity has now been demonstrated in a 
wide range of pancrustacean species. However, with the currently 
available data, it still remains to be demonstrated that recognition 
specificities mediated by Dscam1 splice variant repertoires have 
memory.
Han-Ching Wang
Although there is increasing evidence to suggest that immune 
memory occurs in pancrustaceans, the underlying molecular 
mechanism is still an open question. In pancrustaceans, it has 
long been clear that somatically generated immune factors, such 
as lectins and proPO-related proteins, could not account for 
immune specificity or immune memory. When Dscam1 was dis-
covered, it seemed to have great potential to support these special 
immune responses. Initially, however, most Dscam1 studies were 
performed in short-lived pancrustaceans, which made it difficult 
to investigate its role in immune memory. In a recent, as of yet 
unpublished study, we challenged 200–300 long-lived crayfish 
twice with WSSV, with the second challenge made 14 days after 
the first. We then used gene cloning to determine the expressed 
combinations of Ig2–Ig3 in the Dscam1 populations in collected 
hemocyte samples. In the crayfish that survived both challenges, 
some Dscam1 isoforms with particular Ig2–Ig3 combinations 
showed a good binding affinity with WSSV. Furthermore, these 
isoforms appeared after the first challenge and they increased in 
quantity after the second challenge. This result is consistent with 
the idea that there might be meaningful selection and maintained 
expression of particular Dscam1 exons. Unfortunately, there were 
also complications: first, the expression pattern was not seen in 
every surviving crayfish, and second, each surviving crayfish 
produced different Dscam1 isoforms.
Sophie A. O. Armitage and Joachim Kurtz
We here consider a phenomenological definition of immune 
memory, which has been called “immune priming” in inver-
tebrates and can be described as “the ability of an immune 
system to store or simply use the information on a previously 
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encountered antigen or parasite, upon secondary exposure” 
(31), rather than considering a mechanistic definition invok-
ing the acquired immune system. Since a review (7), where we 
discussed the absence of empirical data on the hypothesis that 
Dscam1 is involved in immune priming, there are at least two 
published studies on this topic (63, 64). The latter study found 
no change in Dscam1 gene expression in a transgenerational 
immune priming study. However, Fu et  al. (63) found that 
shrimp that had fed on bacterial spores harboring a WSSV 
protein, and then received siRNA to knockdown Dscam1, 
were less phagocytically active and had lower survival after 
a subsequent exposure to WSSV compared to shrimp that 
had also been primed with WSSV protein but did not receive 
Dscam1 siRNA. This study would support the hypothesis 
that Dscam1 has some involvement in immune priming, 
but we note that the expression of individual splice variants 
was not tested. If we imagine the hypothesis that Dscam1 
splice-variants are specific for a particular pathogen [this 
was not tested by Fu et al. (63)] it is difficult to conceive the 
mechanism by which Dscam1 could “remember” aspects of 
previously encountered antigens. Variability in the Dscam1 
isoforms comes from somatically generated mRNA via 
mutually exclusive alternative splicing, therefore there would 
need to be some mechanism by which splicing patterns can 
be reproduced. Alternatively the variation in Dscam1 may 
not be important for immune priming, it is just the pres-
ence or absence (reduction) of the protein that affects the 
phenomenon.
Question 4. What Alternatives Are There to an 
Antibody-Like Function of Dscam1 in Pancrustacean 
Immune Systems?
Daniela Brites and Louis Du Pasquier
To sum up, Dscam1 diversity as a whole seems to be the selected 
feature (diversity for diversity’s sake) and we see it best exploited 
in the nervous system i.e., to specify cell identity. “Thus, the 
Dscam1 repertoire of each cell is different from those of its neigh-
bors, providing a potential mechanism for generating unique cell 
identity in the nervous system and elsewhere” (11). We therefore 
suggest that in a manner analogous to what it does in the nervous 
system, Dscam1 on hemocytes might specify hemocyte identity, 
using homologous interactions in the way proposed for neurons 
(20) (see below paragraph 7 a suggestion for a method). Other 
functions could be inferred from understanding better the signal-
ing capacities of the molecule.
Han-Ching Wang
In crustaceans, a pathogen can induce “antibody-like” Dscam1 
isoforms that show specific binding ability to the invading 
pathogen. In shrimp, but not yet in crayfish, we have also 
observed “super Dscam1 isoforms” that have a wider binding 
ability to a range of bacteria and viruses (37). We have also seen 
that while a whole intact pathogen takes ~24 h to induce Dscam1 
expression (37, 43, 44), challenge with pathogen-associated 
molecular patterns (PAMPs), such as lipopolysaccharides (LPS) 
and beta-1-3-glucan and peptidoglycan (PG), induce Dscam1 
expression within just a few hours, after which Dscam1 expression 
levels then decline (41, 42). These findings suggest that, as with 
other innate, non-hypervariable, crustacean immune factors, 
Dscam1 can also be triggered even without any antigen-specific 
recognition. Taking all of these results together, it is tempting to 
propose that it might be the “super Dscam1 isoforms” that are 
responsible for this rapid, non-specific immune response (37). 
A corollary of this proposal is that Dscam1 might therefore be 
regulated by at least two molecular mechanisms: one involved 
in the regulation of Dscam1 expression; the other involved in 
the regulation of alternative splicing to generate specific Dscam1 
isoforms.
Joachim Kurtz
It is important to note that one of the “beauties” of the antibody 
system lies within the fact that antibodies are at the same time 
specific receptors and powerful effectors, such that the specific-
ity of recognition is directly linked to the defensive function. 
However, this does not need to be the case for other immune 
molecules and provides the alternative that in the case of 
Dscam1, there might well be a function as a pathogen receptor 
(the studies demonstrating binding to pathogens support this 
view), but not as an effector (the mixed results regarding expres-
sion changes upon infection and the relatively low expression 
level of Dscam1 in the immune system suggest this). The recep-
tor function could be somewhat similar to the role of Dscam1 
in the nervous system. Hemocytes interact with one another 
when they encapsulate a pathogen or close a wound, while such 
interactions could in the absence of an insult be blocked by 
Dscam1, just as Dscam1 homophilic binding blocks neuronal 
self-interactions. In this context it is intriguing that the parts of 
Dscam1 that are responsible for homophilic interactions differ 
from the potentially pathogen-binding parts (24), so that both 
functions could co-occur. More generally, neuro-immunological 
feedbacks could be involved and link the neuronal function of 
Dscam1 to its immune function. Such feedbacks are for example 
known for the regulation of immune genes by the internal clock 
(65) and it would be worth exploring an immune regulation role 
for Dscam1.
Sophie A. O. Armitage
Dscam1 has been proposed to act as a hypervariable PRR, a 
co-receptor during phagocytosis and an opsonin. As mentioned 
above, in addition to, or instead of, directly interacting with anti-
gens, cell surface expressed Dscam1 might be important for host 
cell–cell interactions, be these from hemocyte to hemocyte, or 
hemocyte to fat body/nervous system/other cell. If these interac-
tions were in the form of homophilic binding, and if each cell has 
a restricted repertoire of isoforms, then the frequency of Dscam1 
homophilic binding between different cells would likely be low. 
Furthermore, if Dscam1 interacts with pathogens, one could 
hypothesize that it also interacts with non-pathogenic micro-
biota found within the host. There are indications that Dscam1 
influences microbiota, more specifically bacteria, in A. gambiae: 
knockdown of Dscam1 increased bacteria in the haemolymph 
(14) and overexpression of a particular Dscam1 variant reduced 
bacteria in the gut (45). In contrast, in the small brown planthop-
per, Laodelphas striatellus, the titer of an extracellular symbiotic 
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bacterium was unaffected by Dscam1 knockdown, and the titers 
of an endosymbiotic bacterium, Wolbachia, and the rice stripe 
virus were even decreased after knockdown (66). It is not clear 
why intracellular passengers would be affected by the knockdown 
of a cell adhesion molecule on the surface of the cell, is it a direct 
effect of the reduction in Dscam1 or does knockdown negatively 
affect the host cells or their behavior in some way, so reducing 
survival for intracellular passengers? These are speculations, but 
it will be interesting to see whether other host–microbe interac-
tions are influenced by Dscam1.
Question 5. What Is the Meaning of Dscam1  
Genetic Diversity?
Daniela Brites and Louis Du Pasquier
Comparative analysis of Dscam1 in different arthropod groups 
has shown that two mechanisms of generating Dscam1 diversity 
have evolved independently; massive whole-gene duplications in 
basal arthropods and the refined mutually exclusive alternative 
splicing of duplicated exons in the Dscam1 of pancrustaceans. 
The ability to generate Dscam1 diversity seems thus to have been 
positively selected in the evolutionary history of arthropods. 
Perhaps because diversity provided means of specifying cell 
identity (e.g., in hemocytes which are important mediators of 
embryonic development). We still know very little about Dscam1 
in basal arthropods, however, the evolution of pancrustacean 
Dscam1 is well studied. We can conclude that in contrast to the 
constitutively expressed domains of Dscam1 which are highly 
conserved, the alternative domains encoded by the alternative 
exons are highly diverse across pancrustaceans. If providing cell 
identity has been the most important driver of Dscam1 diversity 
and that already happened in the most recent common ancestor 
of pancrustaceans, why would each group of pancrustaceans have 
evolved its own set of alternative exons? Could that be driven 
by an additional role in immunity? Then there is the question 
of Dscam1’s polymorphism within species, and what we can 
learn from it. In Dscam1 polymorphism can be understood 
sensu lato both as the variants generated within an individual 
via alternative splicing of duplicated exons of Dscam1, and as 
polymorphism at the population level caused by mutations 
accumulated in orthologous exons in different individuals. The 
first source of polymorphism we have touched upon already and 
we would briefly like to mention what we have learnt from study-
ing Dscam1’s allelic polymorphism. The regions of the variable 
domains that are not involved in the homophilic binding of the 
molecule (so-called epitope II) are more diverse (at the popu-
lation level) than the regions involved in homophilic binding. 
Why are they more diverse? Could these variants be important 
for antigen recognition? Population genetic tests did not provide 
solid evidence supporting that these variants are maintained 
in the population because of antigen recognition, however the 
power of these analyses was low (67). The question of whether 
epitope II could be involved in binding to antigens therefore still 
remains open and should be tested experimentally.
Han-Ching Wang
Although Dscam is a ubiquitous protein that can be found in 
various animal species, such as mammals, fish, mollusks and 
arthropods, I would like to discuss its genetic diversity solely 
in terms of arthropod Dscams. Curiously the ancestral hyper-
variable Dscam1 gene is only found in the pancrustaceans, while 
other arthropods have non-hypervariable Dscam-like genes (68). 
This situation presumably arose due to independent gene dupli-
cation and diversification events that in turn would be driven by 
their adaptive value in the evolution of the Dscam1 gene family 
during Arthropoda evolution (68). It is very likely that this 
evolutionary pressure depended on the functional requirements 
of the arthropod’s nervous system and/or its putative immune 
system, and in this content, it is important to note that the genetic 
diversity of Dscam1 depends on both its extracellular region and 
its intracellular region. The hypervariable Dscam1 extracellular 
region is used for axonal guidance during neuronal development 
and also provides a mechanism that might, at least potentially, 
be used for pathogen recognition (4). But the intracellular 
Dscam1 cytoplasmic tails also show an interesting divergence: 
for instance, although there is a high homology between insect 
Dscam1s, the crustaceans have evolved quite differently, with 
variable cytoplasmic tails in shrimp (34), and a unique tail-less 
form of Dscam1 in shrimp and crab (33–35). Furthermore, the 
secreted insect Dscam1 is generated from membrane-bound 
Dscam1 by a shedding process (47), whereas the more long-
lived crustaceans express the tail-less Dscam1 directly through 
alternative splicing (33–35). The way that this tail-less Dscam1 
is directly expressed bears a thought-provoking resemblance to 
the way that secreted IgM antibodies are expressed in mammals. 
While this might simply be a coincidence, it might also be a 
form of convergent evolution that reflects the importance that 
immune memory should have to a long-lived arthropod (i.e., a 
crustacean) as opposed to arthropods with shorter lifespans (e.g., 
most insects).
Joachim Kurtz
Generally, genetic diversity can come in different flavors: as diver-
sity in the population (i.e., polymorphism) and as diversity within 
each individual. Accordingly, these different types of diversity 
could have different meanings: diversity in the population could 
have arisen from the processes of gene duplication and mutation 
and could be maintained by negative frequency-dependent selec-
tion, for example by parasites. Diversity in the individual might 
further be increased by somatic diversification processes, such as 
alternative splicing in the case of Dscam1. Its meaning could be 
diversity just for its own sake, which seems to be what is going 
on for Dscam1 in the nervous system, so as to enable neuron self/
non-self discrimination. Alternatively, its meaning could be to 
produce immune repertoire diversity so as to recognize diverse 
parasitic antigens. It is interesting to compare with other systems 
[for review see Ref. (31)], where immune diversity sometimes 
stems from massive diversification in the germ-line, such as in 
the case of V region-containing chitin binding proteins (VCBPs) 
in amphioxus, while it mainly comes from somatic diversification 
processes in other systems, such as the vertebrate antibodies and 
maybe the mollusks’ fibrinogen-related proteins (FREPs) and the 
Sp185/333 proteins of sea urchins. For Dscam1, it is still difficult 
to say which of these potential “meanings” of genetic diversity is 
most relevant.
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Sophie A. O. Armitage
Diversity in Dscam1, and more generally in the Dscam gene fam-
ily, operates at different levels. Starting with a broader perspec-
tive, Dscam1 paralogs have been described for insects (39, 68, 69) 
and at least one crustacean (27), showing that diversity exists at 
the level of whole gene duplications. For example in addition to 
Dscam1, the D. melanogaster genome contains Dscam2, Dscam3, 
and Dscam4, of which only Dscam2 has (two) alternatively 
spliced exons in Ig7 (70). Narrowing our perspective to just the 
Dscam1 gene, diversity is found across orthologs in terms the 
number of alternatively spliced exons that have evolved within 
each of the alternatively spliced exon cassettes found in a spe-
cies. For example, from the lower diversity Dscam1 in Daphnia 
magna [8, 24, and 17 alternatively spliced exons in Ig2, Ig3, and 
Ig7, respectively (39)] to higher diversity in Anopheles gambiae 
[14, 30, and 38, respectively (71)]. Reconstructing the evolution-
ary history of alternatively spliced exons across pancrustacean 
species with confidence proved difficult, probably because of the 
relatively short exons and long evolutionary timescale studies 
(68). It was possible to infer orthologs of most of the Ig2 and 
Ig7 variants between comparatively closely related species, i.e., 
D. melanogaster and D. mojavensis; but this was more difficult for 
Ig3, indicating more duplication or deletion events and resulting 
in a faster accumulation of diversity in this cluster of exons com-
pared to Ig2 and Ig7 (68). In contrast, the amino acid sequences 
of the non-alternatively spliced regions in Dscam1 orthologs 
show greater conservation (12). To zoom into the last level, we 
know relatively little about within-species diversity in terms of 
polymorphisms in the conserved or alternatively spliced regions 
of Dscam1 [but see Ref. (67, 72)]. It has been hypothesized that 
because diversity within individuals is generated somatically, that 
one might not expect to find strong signatures of selection in the 
alternatively spliced exons (7, 10).
Question 6. What Was the Main Factor Driving the 
Evolution of Diversity in Dscam1—The Nervous or 
Immune System or Even Something Else?
Han-Ching Wang
It is interesting to note that, just like Dscam, a number of immune 
factors/receptors also play an important role in the neuronal 
system, and in fact there is increasing evidence that both systems 
share several mechanisms and have similar physical properties. 
Currently, however, it is still too early to say whether Dscam1 
diversity evolved dependently or independently of the nervous 
system because work in Dscam1 neuroimmunology is still in its 
infancy in insects and has not even begun in long-lived crusta-
ceans. Even so, based on current knowledge, I tend to believe that 
the diversity in Dscam1 must on some level be driven by immune-
related evolutionary pressure. First, at least in D. melanogaster, the 
ways that Dscam1 alternative exons are used in neural cells and 
immune cells are different (12), suggesting that the regulation and 
exon selection of Dscam1 alternative splicing may be mediated by 
different mechanisms. Second, in shrimp, our experimental data 
showed that recombinant Dscam1 proteins containing various 
Ig2/Ig3 combinations bound more strongly to natural shrimp 
pathogens (such as Vibrio harveyi and WSSV) than to other 
bacteria (Escherichia coli and Staphylococcus aureus) (37). This 
suggested that host–parasite coevolution may have occurred in a 
way that contributed to Dscam1’s hypervariability in immunity.
Joachim Kurtz
We can only speculate here, but when we consider that outside of 
the Pancrustacea, Dscam’s function seems to be only in the brain, 
then it is more likely that Dscam’s role in the nervous system pre-
dates its function in the immune system. So let us assume there 
was an ancient function of Dscam in the brain, what could have 
driven the evolution of diversity? It is not unlikely that there was 
negative frequency-dependent selection, because a rare isoform 
has the advantage that it offers a higher value for the function to 
discriminate neurons. For a rare isoform, few other neurons will 
express the same isoform. However, a novel isoform also bears the 
risk of potentially harmful self-reactivity with any other pattern in 
the organism, leading to selection against self-reactive isoforms, 
i.e., self-reacting Dscam isoforms would be purged from the 
isoform “pool.” As a result, but still predating any immune func-
tion, we could imagine that with Dscam a molecular system has 
evolved that represents “non-self.” This could then have been a 
preadaptation (i.e., an evolutionary “exaptation”) for a system that 
would allow for non-self recognition also outside of the nervous 
system, i.e., a potential pathogen recognition system could have 
emerged. This way, an immune function might have followed 
from a more ancient nervous system function. Once there, selec-
tion pressures from the immune system would kick in and lead 
to further diversification. And finally, there is yet another possible 
initial driving factor for the evolution of diversity: to enable his-
tocompatibility reactions within the species, i.e., allorecognition 
[see, e.g., Ref. (73, 74)], which for example explains the diversity 
at the fuhc locus in the ascidian Botryllus, where the fester gene 
also shows quite extensive alternative splicing [(75); for review 
see Ref. (76)]. Allorecognition systems have likely evolved in 
taxa where chimerism is a relevant problem, such as colonial 
invertebrates, where there is in particular the risk of germ-line 
parasitism. It would thus be interesting to find out whether or 
not chimerism might have played a role in those arthropods that 
initially diversified Dscam1.
Sophie A. O. Armitage
This question is difficult to answer with our current knowledge. 
Considerable data exists describing the function of Dscam1 in 
the nervous system of D. melanogaster [reviewed in Ref. (5, 9)]. 
Dscam1 mRNA is expressed in the brain of other species of 
Pancrustacea [e.g., Daphnia (39)], but our knowledge of how 
Dscam1 functions in the nervous system of these species is less 
well understood. Studies focusing on the function of Dscam1 in 
basal pancrustacean species might help to elucidate the selection 
pressure that maintains current diversity. Perhaps diversity in Ig7, 
which can also be found in non-Dscam1 genes, initially evolved in 
response to different cues to those that resulted in diversity in Ig2 
and Ig3? As detailed above, the Dscam gene family in arthropods 
is highly diverse; what were the selection pressures that lead to 
diversification not only of Dscam1, but also of the Dscam gene 
family in general? Was this the same selection pressure? We know 
that some of the non-highly diversified Dscam genes function 
in the nervous system [e.g., Ref. (69, 70, 77)], do these genes 
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also play immune roles? Do taxa that are evolutionarily basal 
to arthropods, e.g., Onychophora and Tardigrada, have Dscam 
homologs, if so are they diversified and what are the functions 
of these genes?
Question 7. What Are the Future Perspectives for 
Studies on Dscam1 in Immunity? (Including What 
Essential Experiments or Approaches Are Missing 
That Would Help Our Understanding of Dscam1 in 
Immunity?)
Daniela Brites and Louis Du Pasquier
(1) Make more reagents. Raise more monoclonal antibodies 
to follow and play with expression in different species. (2) 
Repertoire analysis. How does restriction of Dscam1 isoform per 
single cell work? How stable is it? Similarly to what happens in 
neurons, does Dscam1 splicing vary overtime in one immune cell 
[e.g., Daphnia (39)]? Use NGS for complete repertoire analysis 
over time after antigenic stimulation of all hemocytes including 
the especially interesting subsets recently discovered (78). (3) 
Cellular assays. Try plaque forming cell assays or ELISPOT assays 
to see whether there is real secretion vs. shedding by hemocytes 
or other cells. The D. melanogaster S2 cells that have been studied 
(48) produce perhaps a reduced repertoire of 15–50 different 
Dscam1 molecular categories/cells but are far from being uncom-
mitted. Proliferating in artificial conditions in vitro, S2 cells are 
not the equivalent of in vivo lymphocytes, but at least they are 
derived from the macrophage-like cell type of D. melanogaster 
and divide every 24  h at 26–28°C. This might still provide an 
in vitro model for understanding Dscam1 signaling, stability of 
expression, and properties of progeny cells within the hematopoi-
etic tissues. (4) Signaling. What are the consequences of ligand/
receptor interactions? The signaling pathways that are known for 
Dscam1 are still controversial (11). A possible relationship with 
the cytoskeleton has been suggested, which could be compatible 
with a role in phagocytosis and/or in cell movement. Dscam1 
mutants should help elucidating this aspect. How does Dscam1 
induction (upregulation) work in the fat body and hemocytes? Is 
it via direct stimulation by Dscam1 receptors themselves, or via a 
cytokine? Or is it via Toll, JAK, or Imd pathways? Are coreceptors 
involved? (5) Exploit more Dscam1 mutants in immunological 
experiments. Test the alternative hypothesis mentioned above 
(i.e., see 4) in Dscam1 mutants. Migration of hemocytes can 
be monitored beautifully in D. melanogaster [(79), this article 
has since been withdrawn]. Following mechanical disturbance 
hemocytes change location and return to their original position 
within 45 min. If Dscam1 plays a role in controlling migration 
of hemocytes, Dscam1 mutants should show differences in 
relocation after disturbance, the prediction being that the cells 
would not return properly to their location. But perhaps the pat-
tern of hemocytes distribution in mutants would be abnormal 
even without disturbance! (6) Specificity of binding. One should 
explore the binding properties of Dscam1 proteins to heterolo-
gous ligands to confirm its potential as a receptor or an effector. 
In addition, study the precise binding properties of Dscam1, 
with proteins encoded for by different exon combinations, to 
determine the specificity of binding heterologous ligands (if any). 
Go back to testing further the epitope I–epitope II hypothesis, 
with the in vitro production of Dscam1 molecules, similarly to 
what was done by Watson et al. (80). (7) Comparative functional 
approaches. Study the role of Dscam in basal arthropods. Are the 
functions of the Dscam1 molecules all analogous to each other? 
Are they redundant? Compare again hemocytes versus other cells 
and investigate the presence of soluble forms.
Yuemei Dong
Many questions remain to be answered, such as how many splice 
variants (or groups of variants, so called “Dscam1 clouds”) are 
produced uniquely or whether there is a continuous range. 
Moreover, the essential questions regarding the stability of the 
pathogen specific Dscam1 isoform repertoires after selection, 
and whether the expression of Dscam1 clouds in the renewing 
population are regulated, remain to be addressed.
Han-Ching Wang
There are still many missing pieces in the puzzle of Dscam1-
mediated immunity, even in terms of Dscam1’s general prop-
erties. For instance, we still do not have a complete picture of 
Dscam1’s response at the mRNA level and protein level after 
one or multiple stimulations with various immune stimulators. 
Part of the difficulty in Dscam1 research is due to the fact that 
it cannot easily be silenced in  vivo in long-lived crustaceans, 
such as shrimp and crayfish (unpublished data). Clearly, there 
is a need to develop an alternative in vivo system to test Dscam1 
function, especially for long-term observations. As for Dscam1’s 
immune diversity, the main questions to be addressed are which 
factors are involved in Dscam1 alternative splicing and which 
mechanisms support the generation and maintenance of the 
specific Dscam1 isoforms after pathogen challenge. Meanwhile, 
regarding Dscam1’s immune specificity, instead of just focus-
ing on one particular highly expressed exon variant, we should 
investigate how the entire Ig2/Ig3/Ig7 combination is involved 
in specific binding with the corresponding pathogen. We would 
also like to know which kinds of epitopes on a particular patho-
gen can be recognized by the corresponding pathogen-induced 
Dscam1 isoforms: does Dscam1 bind with these pathogens 
through the recognition of general PAMPs or by recognizing 
particular antigens as pathogen surface proteins? Finally, the 
question of immune memory is perhaps the most difficult of 
all. Our current approach is to document the dynamics of the 
Dscam1 isoform population in long-lived pancrustaceans after 
multiple stimulations. From this, we hope to establish whether 
or not some specific Dscam1 isoforms are consistently present 
after specific pathogen stimulation. Other open questions 
include: which cell types might act as immune memory cells? 
Are the kinds of pathogen-specific Dscam1 isoforms expressed 
after pathogen stimulation only produced by particular cells (or 
cell types)? At present, we are still a long way from answering 
these questions. Given that penaeid shrimp culture is a global 
economic activity that is vulnerable to economic losses from 
outbreaks of viral and bacterial diseases, the study of Dscam1-
mediated immunity is also of practical importance. For example, 
a clear understanding of the mechanism of Dscam1-mediated 
immunity should provide a scientific basis for optimizing 
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shrimp vaccination strategies. We therefore believe that further 
research into Dscam1 has great potential and should very much 
be encouraged.
Sophie A. O. Armitage and Joachim Kurtz
In addition to the abovementioned ideas we would add: (1) test 
whether epitope II indeed binds to pathogen/parasites, and if so, 
uncover what the specific binding partner is; are there conserved 
aspects of e.g., viruses, bacteria, fungi, or other parasites that are 
involved? (2) next, generation sequencing of mRNA alternative 
splicing patterns of exons 4, 6, and 9 [e.g., Ref. (81)], for example, 
using the A. gambiae—Plasmodium interaction or crustacean—
WSSV interactions, which seem to be particularly promising to 
understand Dscam1 in immunity; (3) as an extension to the previ-
ous point, applying peptide sequencing to Dscam1 after infection 
with a pathogen or parasite to test the variability in alternatively 
spliced sequences at the protein level; also determine for how long 
the protein persists in the haemolymph (particularly in relation 
to knock-down studies); (4) test whether Dscam1 is involved 
in specific immune memory by varying the identity of the 
primary and secondary pathogen/parasite in conjunction with 
Dscam knockdown before the primary and/or before the second 
pathogen/parasite exposure; and (5) it could be interesting to 
further characterize the influence of Dscam1 on microbiota.
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